Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bath

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Lancet. Neurology|July 10, 2003
Anticoagulants and antiplatelet agents in acute ischaemic strokePhilip Bath
Lancet (London, England)|November 9, 2004
Role of aspirin in MATCHPhilip Bath
Cerebrovascular Diseases (Basel, Switzerland)|December 25, 2003
High blood pressure as risk factor and prognostic predictor in acute ischaemic stroke: when and how to treat it?Philip Bath
Stroke|February 9, 2002
Re: Stroke Therapy Academic Industry Roundtable II (STAIR-II)Philip Bath
Stroke|April 19, 2003
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the keyPhilip Bath
Current Opinion in Neurology|December 30, 2009
Blood pressure treatment in acute ischemic stroke: a review of studies and recommendationsGeorge Ntaios, Philip Bath, Patrik Michel
Stroke|October 25, 2003
Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic reviewParveen Rashid, Jo Leonardi-Bee, Philip Bath
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic reviewPhilip Bath, Jo Leonardi-Bee, Fiona Bath
Stroke|February 21, 2004
Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular diseasePhilip Bath, Charles Algert, Neil Chapman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Triple antiplatelet therapy for secondary prevention of recurrent ischemic strokeMark Willmot, Lian Zhao, Stan Heptinstall, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Lancet. Neurology|July 10, 2003
Anticoagulants and antiplatelet agents in acute ischaemic strokePhilip Bath
Lancet (London, England)|November 9, 2004
Role of aspirin in MATCHPhilip Bath
Cerebrovascular Diseases (Basel, Switzerland)|December 25, 2003
High blood pressure as risk factor and prognostic predictor in acute ischaemic stroke: when and how to treat it?Philip Bath
Stroke|February 9, 2002
Re: Stroke Therapy Academic Industry Roundtable II (STAIR-II)Philip Bath
Stroke|April 19, 2003
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the keyPhilip Bath
Current Opinion in Neurology|December 30, 2009
Blood pressure treatment in acute ischemic stroke: a review of studies and recommendationsGeorge Ntaios, Philip Bath, Patrik Michel
Stroke|October 25, 2003
Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic reviewParveen Rashid, Jo Leonardi-Bee, Philip Bath
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic reviewPhilip Bath, Jo Leonardi-Bee, Fiona Bath
Stroke|February 21, 2004
Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular diseasePhilip Bath, Charles Algert, Neil Chapman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Triple antiplatelet therapy for secondary prevention of recurrent ischemic strokeMark Willmot, Lian Zhao, Stan Heptinstall, et al.
Pageof 5